Both share identical purity standards and third-party testing
No human or animal cells or tissues were used as experimental subjects in the study
All case series and reports 151,152,153,154,155 reported better metabolic outcomes in patients with comorbid severe mental illness and diabetes and/or obesity who were concomitantly treated with antipsychotics and GLP-1RAs
Some patients have reported using compounded versions of tirzepatide at lower concentrations to facilitate microdosing, though the FDA has issued warnings about the risks of compounded GLP-1 receptor agonists, including concerns about quality, potency, dosing errors, and different salt forms
291 , R367R375 (2006)
Temperature excursions above 77 degrees Fahrenheit cause accelerated degradation of the peptide